Chae Ok Yun, Founder & CEO – GeneMedicine

Chae Ok Yun Founder and CEO of GeneMedicine, Dr Chae-Ok Yun, explains how the company, specialised in oncolytic virus development, has progressed since we last interviewed her two years ago, with one of its candidates getting close to phase II clinical trials and the construction of a new manufacturing facility that will enable GeneMedicine to grow its CDMO business.
Our preclinical data and clinical experience with our pipelines have been highly promising, and we are eager to advance our clinical trials to later stages.
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report